1. Home
  2. BRAI vs GPCR Comparison

BRAI vs GPCR Comparison

Compare BRAI & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRAI

Braiin Limited Common Stock

N/A

Current Price

$12.49

Market Cap

2.6B

Sector

N/A

ML Signal

N/A

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$39.16

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRAI
GPCR
Founded
N/A
2016
Country
Australia
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
BRAI
GPCR
Price
$12.49
$39.16
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
$103.17
AVG Volume (30 Days)
494.7K
666.6K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.62
$15.80
52 Week High
$32.32
$94.90

Technical Indicators

Market Signals
Indicator
BRAI
GPCR
Relative Strength Index (RSI) 53.64 41.61
Support Level $12.56 $35.78
Resistance Level $27.42 $40.29
Average True Range (ATR) 1.82 1.92
MACD 1.19 0.69
Stochastic Oscillator 49.45 58.92

Price Performance

Historical Comparison
BRAI
GPCR

About BRAI Braiin Limited Common Stock

Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: